Table 4 Baseline characteristics of the patients who received transplantation during follow-up stratified by study
| Â | CONTRAST | ESHOL | French study | Turkish study | p-value |
|---|---|---|---|---|---|
N | 151 (21.1) | 180 (19.6) | 7 (1.8) | 17 (2.2) | Â |
Age (year) | 53.4 (12.3) | 54.4 (12.3) | 67.7 (2.7) | 44.5 (12.9) | < 0.001 |
Female sex | 63 (41.7) | 60 (33.3) | 3 (42.9) | 7 (41.2) | 0.446 |
History of CVD | 33 (21.9) | 34 (18.9) | – | 3 (33.3) | 0.364 |
Diabetes mellitus | 30 (20.3) | 27 (15.0) | 1 (16.7) | 5 (29.4) | 0.372 |
Dialysis vintage (months)* | 26.0 (14.0–44.0) | 23.0 (10.8–44.3) | 32.3 (21.7–48.7) | 55.8 (27.8–75.0) | 0.013 |
Systolic BP (mmHg) | 147.6 (21.5) | 136.5 (20.0) | 141.7 (24.6) | 125.9 (11.0) | < 0.001 |
Diastolic BP (mmHg) | 80.0 (10.7) | 76.3 (13.3) | 72.5 (5.8) | 74.7 (7.8) | 0.017 |
Vascular access, AVF | 130 (86.1) | 170 (94.4) | 3 (42.9) | 15 (88.2) | < 0.001 |
Duration of a dialysis session (min) | 227.6 (22.1) | 237.8 (18.9) | 225.0 (36.7) | 237.5 (3.6) | < 0.001 |
Blood flow (ml/min)* | 300 (275–325) | 400 (350–400) | 310 (300–335) | 309.2 (297.4–346.3) | < 0.001 |
Dialysis single pool Kt/V | 1.4 (0.2) | 1.7 (0.3) | 1.7 (0.2) | 1.4 (0.3) | < 0.001 |
Hemoglobin (g/dL) | 11.9 (1.1) | 12.2 (1.3) | 11.0 (1.4) | 11.8 (1.3) | 0.013 |
Phosphorus (mg/dL) | 5.2 (1.5) | 5.0 (1.4) | 4.5 (1.9) | 4.9 (1.1) | 0.291 |
B-2 microglobulin (mg/L)* | 32.3 (24.6–40.7) | 20.9 (16.3–26.9) | 23.0 (21.0–27.2) | 26.2 (23.9–28.3) | < 0.001 |
BMI after dialysis (kg/m2) | 24.9 (3.7) | 24.8 (4.2) | 24.1 (1.6) | 24.4 (5.0) | 0.934 |
Albumin (g/dL) | 4.1 (0.4) | 4.2 (0.4) | 4.0 (0.4) | 4.0 (0.3) | 0.108 |
C-reactive protein (mg/L)* | 2.3 (0.9–6.8) | 5.0 (2.6–10.4) | 1.9 (0.9–6.6) | 1.0 (0.2–1.3) | < 0.001 |
Predialysis creatinine (mg/dL) | 11.1 (2.6) | 8.6 (2.4) | 7.3 (2.4) | 9.1 (2.2) | < 0.001 |
Cholesterol (mmol/L) | 3.7 (1.1) | – | 4.7 (1.2) | 4.5 (1.1) | 0.001 |
Body Surface Area (m2) | 1.9 (0.2) | 1.8 (0.2) | 1.7 (0.2) | 1.7 (0.2) | < 0.001 |